Health

Avoiding a kidney calamity: A matter of numbers

With recognition growing that intervening early is possible and beneficial, primary care doctors are taking a more active role in treating chronic kidney disease.

By Victoria Stagg Elliott — Posted Oct. 2, 2006

Print  |   Email  |   Respond  |   Reprints  |   Like Facebook  |   Share Twitter  |   Tweet Linkedin

Just a few years ago, kidney care did not rank high on the priority list of family physician Chester Fox, MD. That changed after he participated in a National Kidney Foundation event designed to raise awareness about what primary care physicians can do for patients who have chronic kidney disease. As a result, he decided to review his charts and think more carefully about the role this organ played in his patients' overall health.

"I started looking at my hypertensives and diabetics, and it was scary," said Dr. Fox, professor of clinical family medicine at the University at Buffalo -- State University of New York. "I thought I was doing a decent job, but I was ignoring elevated creatinines. A lot of them had mild anemia that I was ignoring."

He now speaks regularly on why kidney care is important to primary care physicians and is one of a growing number of non-nephrologists who are paying more attention to it because of a convergence of population-wide health trends and new data suggesting that early action is both feasible and important.

One of the most notable factors driving interest is the sheer number of people who have some form of kidney disease. According to a study published in the January 2003 American Journal of Kidney Diseases, an estimated 19.2 million people have some form of it. The number of patients on dialysis or in need of a transplant is approaching half a million and increasing approximately 4% per year, according to the U.S. Renal Data System, which tracks end-stage kidney disease.

"It's been unappreciated that it's as prevalent as it is," said Anton Schoolwerth, MD, MSHA, a nephrologist at Dartmouth-Hitchcock Medical Center in Lebanon, N.H., who is consulting with the Centers for Disease Control and Prevention on the possibility of related public health activities.

That prevalence has highlighted the need to widen the net in terms of diagnosis and treatment. State programs that fund care for end-stage kidney disease regularly run out of money, and nephrology organizations are increasingly asking primary care physicians and other specialties to share in treating this population.

"There are just too many patients out there with chronic kidney disease. It will be impossible for nephrologists to care for them all," said Mark Rosenberg, MD, director of the division of renal diseases and hypertension at the University of Minnesota in Minneapolis. He gave a presentation on this issue at the American College of Physicians meeting in Philadelphia earlier this year.

Many experts blame the increasing numbers on the rise in obesity, which is leading to soaring rates of diabetes and hypertension. Not only are more people developing these conditions, but they are living long enough -- because of improvements in care -- to develop kidney complications and other downstream effects.

Another explanation is that testing for earlier forms of kidney disease has become easier.

But incident rates are not the only reason nephrologists are asking for assistance. Evidence is mounting that even minor kidney complications are significant and that care needs to occur in the early stages.

"Any intervention that we do that will be meaningful for the patients, society and public health will be early intervention, and early intervention means that the patients have not yet been referred to a specialist," said Arnold Berns, MD, co-chair of the American Society of Nephrology's Practicing Nephrologists Advisory Group and clinical professor of medicine at the University of Illinois College of Medicine in Chicago.

The vast majority of those with chronic kidney disease never reach the late stages because they die of cardiovascular disease when damage to the heart is accelerated by damage in the kidneys. Most recently, a study published in the September Diabetes Care found that those with type 2 diabetes who had kidney disease, even if it was very mild, had a significantly increased risk of death, mostly from heart disease.

"Patients die before they can develop end-stage kidney disease, but yet they have chronic kidney disease as the underlying and overarching problem accelerating their cardiovascular disease," said Craig B. Langman, MD, head of the division of kidney disease at Children's Memorial Hospital in Chicago.

The heart-kidney link is not fully understood, but it is being acknowledged by organizations outside the kidney field. The American Heart Assn. issued a scientific advisory in August saying that all cardiovascular disease patients should have their kidney function assessed.

"Because kidney disease is a risk factor, it's important to know that in patients who are either at risk or have proven cardiovascular disease because you'll want to intervene to try and modify that just like you'd modify other risk factors," said Frank Brosius, MD, lead author of the advisory and division chief of nephrology at the University of Michigan, Ann Arbor.

Positive signs

The good news, though, is that it has become more possible than ever to detect kidney disease and interrupt its course, particularly in the primary care setting.

"For most of my career, the feeling was that if someone gets chronic kidney disease, then there's an inexorable march towards kidney failure," said Susan Snyder, MD, vice chair of the department of family medicine at Harbor-UCLA Medical Center. "We now know that there are a number of interventions that can really slow down the progression. There's more and more reason to find it early and intervene."

Detection, once the disease starts, is fairly straightforward. The days of needing a 24-hour urine collection to assess kidney function are over for most patients. The National Kidney Foundation's Kidney Disease Outcomes Quality Initiative guidelines, the most widely accepted, recommend using the estimated glomerular filtration rate, or eGFR, which is frequently included routinely as a part of a metabolic panel. Even if it isn't, serum creatinine almost always is, and this number can be plugged into a formula widely available online to get the eGFR. Proteinuria can also be detected with a dipstick test in a random urine sample.

"It's just a very feasible thing to test," said Michael Shlipak, MD, MPH, division chief of general internal medicine at the San Francisco VA Medical Center, who has been researching markers for pre-clinical kidney disease.

Taking action in response to the eGFR is also relatively uncomplicated. Prevention before kidney damage occurs requires the same lifestyle interventions needed for overall health. When kidney damage becomes apparent, treatment may not be radically different from what is already being done for the patient's other conditions, although it does become more important to reach various treatment goals.

"If someone is identified as having chronic kidney disease, that is a really strong motivating factor for being particularly aggressive," said Andrew S. Narva, MD, director of the National Kidney Disease Education Program run by the National Institute of Diabetes and Digestive and Kidney Diseases.

Anemia and bone disease related to kidney dysfunction should be looked for and attended to. Dyslipidemia should be treated aggressively. Blood pressure control for those who have hypertension and blood sugar control for those with diabetes both should be tightened. But the kidney needs to be considered in all treatment decisions. Specifically, some medications should be avoided while others are preferred.

"This population is different enough that once you find it, the targets are different," said Allan J. Collins, MD, NKF president-elect and director of the renal data system.

For example, diuretics are often the first-line treatment for many patients with hypertension, but for those who also have evidence of kidney damage, angiotensin-converting enzyme inhibitors and angiotensin receptor blockers may be the better course.

"ACE inhibitors and ARBs have kind of revolutionized the ability of primary care doctors to make a positive difference in early kidney disease," said Terry L. Mills, MD, a family physician in Newton, Kan. "They've made it easy."

Obviously, detection and treatment are very feasible. It is the barriers to addressing the problem once diagnosed that can be significant. Primary care medical societies are providing more educational sessions, but several studies have suggested that many physicians are not aware of the NKF guidelines.

"A lot of education is needed," said Dr. Snyder. "We have to work on the attitude that there's nothing to do about chronic kidney disease, because there is a lot to do now."

Kidney function can also decline without producing any symptoms until significant intervention is needed. Thus, it may not be something that patients ask about in the early stages. It can also get lost in the myriad of other things that need to be done in a primary care visit.

"Primary care physicians are dealing with multiple medical problems and tend to have patients with multiple chronic illnesses, of which kidney disease is just one of those," said L. Ebony Boulware, MD, MPH, assistant professor of medicine and a general internist at Johns Hopkins University in Baltimore.

Many experts have great hopes. They are encouraged by the level of attention being paid to patients at the early stages and expect it will lead to fewer patients being placed on dialysis or in need of a transplant. More importantly, they see the earlier action leading to reductions in the number of deaths linked to kidney damage. Anecdotal evidence suggests this may be possible. Before Dr. Fox began focusing on kidney care, patients he referred to nephrologists would generally end up on dialysis almost immediately. This is no longer the case.

"I was able to change my practice very rapidly in six months and do a much better job of caring for chronic kidney disease," he said. "The last three patients I sent to the nephrologists who were supposed to need dialysis have all stabilized. That may just be a lucky streak, but it's very gratifying."

Back to top


ADDITIONAL INFORMATION

Counting kidneys

[download pdf]

Researchers believe that about 19.2 million Americans, or 11% of the population, have some form of chronic kidney disease. These numbers are expected to keep climbing. The number of patients with end-stage renal disease is also on the rise:

1980 58,913
1981 67,618
1982 77,048
1983 89,808
1984 100,651
1985 111,322
1986 122,985
1987 135,841
1988 149,706
1989 166,325
1990 184,271
1991 204,828
1992 225,716
1993 245,595
1994 267,613
1995 286,830
1996 308,171
1997 329,058
1998 350,651
1999 371,105
2000 391,232
2001 409,298
2002 428,198
2003 446,401
Projection
for 2010
651,330

Source: "2005 U.S. Renal Data System Annual Report," American Journal of Kidney Diseases, January 2003

Back to top


External links

United States Renal Data System (link)

National Kidney Disease Education Program on chronic kidney disease (link)

"Detection of Chronic Kidney Disease in Patients With or at Increased Risk of Cardiovascular Disease," a science advisory developed in collaboration with the National Kidney Foundation, abstract, Circulation, Sept. 5 (link)

National Kidney Foundation's Kidney Disease Outcomes Quality Initiative (link)

Back to top


ADVERTISEMENT

ADVERTISE HERE


Featured
Read story

Confronting bias against obese patients

Medical educators are starting to raise awareness about how weight-related stigma can impair patient-physician communication and the treatment of obesity. Read story


Read story

Goodbye

American Medical News is ceasing publication after 55 years of serving physicians by keeping them informed of their rapidly changing profession. Read story


Read story

Policing medical practice employees after work

Doctors can try to regulate staff actions outside the office, but they must watch what they try to stamp out and how they do it. Read story


Read story

Diabetes prevention: Set on a course for lifestyle change

The YMCA's evidence-based program is helping prediabetic patients eat right, get active and lose weight. Read story


Read story

Medicaid's muddled preventive care picture

The health system reform law promises no-cost coverage of a lengthy list of screenings and other prevention services, but some beneficiaries still might miss out. Read story


Read story

How to get tax breaks for your medical practice

Federal, state and local governments offer doctors incentives because practices are recognized as economic engines. But physicians must know how and where to find them. Read story


Read story

Advance pay ACOs: A down payment on Medicare's future

Accountable care organizations that pay doctors up-front bring practice improvements, but it's unclear yet if program actuaries will see a return on investment. Read story


Read story

Physician liability: Your team, your legal risk

When health care team members drop the ball, it's often doctors who end up in court. How can physicians improve such care and avoid risks? Read story

  • Stay informed
  • Twitter
  • Facebook
  • RSS
  • LinkedIn